Piper Sandler Upgrades Alpha Tau Medical to Overweight, Raises Price Target to $22
Benzinga Newsdesk 6 hours ago
Analyst RatingsNewsUpgradesPrice Target
Piper Sandler analyst Allison Bratzel upgrades Alpha Tau Medical (NASDAQ:DRTS) from Neutral to Overweight and raises the price target from $8 to $22.
Piper Sandler analyst Allison Bratzel upgrades Alpha Tau Medical (NASDAQ:DRTS) from Neutral to Overweight and raises the price target from $8 to $22.